Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 8.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 9.00
  • 52 Week Low: 2.25
  • Currency: UK Pounds
  • Shares Issued: 1,061.80m
  • Volume: 1,421,281
  • Market Cap: £84.94m
Select chart: 1 month | 6 month
 

Current

1 month

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 54.37 (9.63) (1.27)p n/a n/a n/a n/a 0.0%
31-Dec-26 81.33 2.17 (0.32)p n/a n/a n/a n/a 0.0%
31-Dec-27 123.75 25.85 1.68p 4.7 n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2025 54 n/a n/a n/a 46 n/a
31-Dec-2026 81 n/a n/a n/a 64 n/a
31-Dec-2027 124 n/a n/a n/a n/a n/a
 
Earnings
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 1.68p n/a n/a n/a n/a n/a
 
Dividend
31-Dec-2025 n/a n/a n/a n/a n/a n/a
31-Dec-2026 n/a n/a n/a n/a n/a n/a
31-Dec-2027 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 0 1 0 1 0
Buy 1 0 0 0 0 0
Neutral 0 0 1 0 1 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 2 0 2 0 2 0
 
Average Rec 8.75 n/a 7.50 n/a 7.50 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 8.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 9.00
52 Week Low 2.25
Volume 1,421,281
Shares Issued 1,061.80m
Market Cap £84.94m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 13-Oct-2025

Time Volume / Share Price
16:35 20,000 @ 8.00p
16:35 20,000 @ 8.00p
16:27 25,406 @ 8.00p
16:25 1,130 @ 7.88p
15:53 97,777 @ 7.93p

STX Key Personnel

CEO Anders Lundstrom

Top of Page